TNM stage, tumor size, organ invasion, and Ki‐67 index have been included in the prognostic system by the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC), but factors such as age, sex, tumor number or therapy methods are still lacking.8, 9. This evidence concerns the gene MKI67 and neoplasm.